Legitimate Opioid Use Amongst Parents Associated with Adolescent Opioid Misuse

A recent study from Columbia University has found that parental opioid use, not misuse, is associated with adolescent medical prescription opioid use and misuse. The study was conducted on nationally representative 15,200 parent-adolescent dyads from the National Survey on Drug Use and Health. The data showed that 18.6% of adolescents used prescription opioids when their parents used opioids as medically prescribed. Comparatively, 14.3% of adolescents used opioids when their parents didn’t use or misused opioids. The significance of this information lies within the fact that youth who use prescription opioids are more likely to be diagnosed with an opioid use disorder by age 25, experience substance-use related morbidity and mortality, be treated for alcohol use disorder, be convicted of a crime, and/or commit suicide. This study suggests that alterations in prescribing patterns and education about storing prescription opioids in homes should be targets on interventions for reducing adolescent opioid use.

Opioid Overdose Deaths and Opioid Use Disorder Cost the US $1.02 trillion in 2017

Fatal opioid overdoses and opioid use disorders cost the United States $1.02 trillion in 2017. The most complete accounting to date of America’s opioid crisis was released by CDC in the journal Drug and Alcohol Dependence. This is a substantial increase from the 2015 estimate of $500 billion. The costs include: health care ($31.3 billion), opioid use disorder treatment ($3.5 billion), criminal justice ($14.8 billion), and lost work productivity ($100 billion).The majority of the economic burden can be attributed to loss of life due to fatal opioid overdose ($480.7 billion) and reduced quality of life from opioid use disorder ($390 billion). The cost estimation helps us understand the impact of the opioid epidemic and helps inform public policy, clinical practice, research, and prevention and response activities.

Study Participants Needed

Study Title: Exploring Barriers and Facilitators in Adopting Medication- Assisted Treatment (MAT): Perceptions of Health Providers in Seven Southern Indiana Rural Counties

 A joint research venture between the IU School of Public Health and the IU Center for Rural Engagement are in need of participants for their study efforts. The goal of the research is to recognize factors that affect the uptake of medication-assisted treatment (MAT) as perceived by healthcare providers. The study is set for rural Indiana counties. Participants must meet the following the requirements:

• Be 18 years of age or older 
• Work with or have professional contact with individuals living with opioid dependency 
• You must live or work in one of the following counties: Orange, Lawrence, Washington, Jennings, Scott, Harrison or Gibson.

The participants will be asked to attend a 30-60 minute one-one-one virtual or phone interview. A $20 gift card will be given to participants at the end of the interview.

For more information contact:

Josephine Mwangi | 740-2497599 (telephone) | jomwangi@iu.edu(email)

Follow us! @INDTrauma

Check out our website:

UPCOMING EVENTS

How a Systems-based Approach Can Change Opioid Prescribing in Primary Care

Washington State OD2A Peer-to-Peer Webinar

1 p.m. – 2 p.m. EST Tuesday, Jan. 26, 2021

This webinar will focus on the Six Building Blocks Program,  an evidence-based quality improvement framework to help primary care teams implement effective, guideline-driven care for their chronic pain and long-term opioid therapy patients. The program will describe a systems-based approach and why it is effective. It will be followed by small and large group discussion, so participants can share ideas and experiences. The webinar is limited to 30 people to facilitate lively discussions.

Click here to register

Indiana Opioid Echo - Virtual ECHO Clinic for Treatment of Opioid Use Disorder and Stimulant Use Disorder

Noon – 1 p.m., Wednesdays (Series), January – March 2021

This free TeleECHO clinic aims to teach participants on how to identify and manage patients with opioid use disorder (OUD) and stimulant use disorder (SUD). The goal is to have a team of experts present on information related to medication-assisted treatment and continuity of care increase clinical competence in treating OUD and SUD. It is designed as a drop-in model, so attendance every week is not necessary. Additionally, this is an opportunity to gather CME credits, each session counts for one credit.

Upcoming sessions:

Jan 27 - Connection of Human Trafficking to SUD & How to Identify

Feb. 3 - Induction of Medications used for OUD

Click here to register and get a complete list of all upcoming sessions.

2021 Opioid Prescribing and Abuse Webinar Series

In 2021, the Indiana State Medical Association (ISMA) is introducing a new series of monthly live webinars on opioid prescribing and abuse. Each webinar, presented the second Thursday of each month at noon ET, counts toward the two hours of continuing medical education (CME) required to obtain or renew a Controlled Substances Registration in Indiana. These webinars are free for ISMA members. All webinars will be recorded and will be available to ISMA members at no charge on the ISMA Online app as a benefit of membership.

To register:
Feb. 11: Opioid Use in Palliative Care (Timothy J. Broach, MD)

March 11: Opioid Use in Hospice Care (Timothy J. Broach, MD)